Huifeng Niu
- Immunology top 10%
-
- Lymphoma Diagnosis and Treatment 3
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 5
- Oncology top 10%
- Cancer-related Molecular Pathways 4
- Lung Cancer Research Studies 2
-
- Melanoma and MAPK Pathways 3
- Ubiquitin and proteasome pathways 3
- RNA modifications and cancer 2
-
- Probiotics and Fermented Foods 2
Huifeng Niu
24 papers receiving 979 citations
Peers
Comparison fields: 5 of 74
- Immunology 322
- Pathology and Forensic Medicine 246
- Genetics 140
- Oncology 351
- Cancer Research 122
Countries citing papers authored by Huifeng Niu
This map shows the geographic impact of Huifeng Niu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huifeng Niu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huifeng Niu more than expected).
Fields of papers citing papers by Huifeng Niu
This network shows the impact of papers produced by Huifeng Niu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huifeng Niu. The network helps show where Huifeng Niu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Huifeng Niu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 6 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 2 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 7 | |
| 6 | 2022 | 8 | |
| 7 | 2017 | 1 | |
| 8 | 2013 | 61 | |
| 9 | 2010 | 23 | |
| 10 | 2010 | 8 | |
| 11 | 2009 | 30 | |
| 12 | 2008 | 11 | |
| 13 | 2005 | 271 | |
| 14 | 2004 | 9 | |
| 15 | 2002 | 8 | |
| 16 | 1999 | 56 | |
| 17 | 1998 | 239 | |
| 18 | 1996 | 2 | |
| 19 | BCL-6 in diffuse large-cell lymphomas. | 1996 | 15 |
| 20 | 1994 | 24 |
About Huifeng Niu
Huifeng Niu is a scholar working on Genetics, Oncology and Pathology and Forensic Medicine, having authored 24 papers that have together received 996 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (5 papers), Cancer-related Molecular Pathways (4 papers), Melanoma and MAPK Pathways (3 papers), Ubiquitin and proteasome pathways (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Probiotics and Fermented Foods (2 papers), Lung Cancer Research Studies (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Immunology (322 citations), Pathology and Forensic Medicine (246 citations) and Genetics (140 citations). Huifeng Niu has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include Riccardo Dalla‐Favera, Katia Basso, Masumichi Saito, Ryan T. Phan, Giorgio Cattoretti, Zheng Pan, Anthony A. Amin, J Hurwitz, Erna L. Gibbs and Laura Pasqualucci. Their work appears in journals such as Proceedings of the National Academy of Sciences, Genes & Development and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.